Yarra BiosystemsThe Right Treatment, Before the First Dose.
Boulder, Colorado Site coming soon

Understanding how tissues function and respond.

Yarra Biosystems is an early-stage life sciences technology company building a platform for spatial tissue analysis, beginning in oncology.

Early-stage · Pre-launch Oncology first

Figure — multiplexed immunofluorescence, representative

01 — Mission

Biology read in place, not in isolation.

Tissue behaviour depends on context: which cells are present, where they sit, and how they relate to one another. Yarra Biosystems is building a platform that measures and interprets that context, beginning with oncology.

The company is based in Boulder, Colorado, and is developing the platform alongside academic and clinical collaborators.

Tissue architecture in section
Cell-to-cell interaction, illustrative
02 — Approach Read the approach
01

Spatial biology

Measurement that keeps cellular observations in their tissue context.

02

Pathology

Grounded in how tissue is prepared and read in practice today.

03

Imaging

Advanced imaging and immunofluorescence to resolve signal across a section.

04

Intelligence layer

A developing analysis layer for interpretation of what is measured.

03 — Momentum

The company has taken part in university venture and commercialization programs, broadened its academic and technical network, and is pursuing non-dilutive funding.

Talking with investors, partners, and collaborators.

Get in touch
Approach

Four capabilities, one view of the tissue.

The platform brings together capabilities that are usually kept apart, so that measurement, established diagnostic practice, and analysis inform one another rather than sitting in separate workflows.

01

Spatial biology

Cells are measured where they sit. Retaining spatial position means the relationships between cell populations, structures, and their surroundings remain available for analysis instead of being averaged away.

02

Pathology

The work is anchored in how tissue is handled and read today. Staying close to established diagnostic practice keeps the platform interpretable to the people who already assess tissue.

03

Imaging and immunofluorescence

Advanced imaging and immunofluorescence resolve multiple signals across a section, giving the analysis layer a richer and more consistent record of the tissue to work from.

04

Intelligence layer

A developing analysis layer draws the measurements together into descriptions of tissue state that a scientist or clinician can reason about. It is under active development.

Instrumentation and analysis, representative laboratory setting

These pages describe the platform at a high level. Component-level and mechanism-level detail is shared with partners under confidentiality.

For a fuller picture, start a conversation.

Contact us
Contact

Let’s Connect.

We read every message and respond directly. Investors, strategic partners, academic and technical collaborators, and prospective advisors are all welcome.

Yarra Biosystems Boulder, Colorado

Message received.

Thank you — we will be in touch shortly.